Komori
Share Issuance and Disposal4884Kringle Pharma,Inc.Pharmaceuticals

(Correction) Partial Correction to the "Notice Concerning the Issuance of Stock Options (Share Acquisition Rights)"

Regarding the issuance terms for the stock options announced on 10 June 2026, the end date of the exercise period for the stock acquisition rights was corrected from 25 June 2036 to 10 June 2036.

Worth reading
29Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

The document this correction applies to

Timely disclosure
Notice Concerning the Issuance of Stock Options (Share Acquisition Rights)2026-06-10

What was corrected and how

A subsequent correction by the company to the contents of an already published filing.

Original disclosure10 June 2026

Notice Concerning the Issuance of Stock Options (Share Acquisition Rights)

Open the original document
19 daysThe pre-correction wording stayed published for this period (Calculated from the Original Disclosure Date Indicated in the Document)
This correction2026-06-29
Location of correction (where in the original document)

2. Issuance Terms for the Stock Acquisition Rights (4) Period during Which the Stock Acquisition Rights May Be Exercised

Before correction

26 June 2028 to 25 June 2036

After correction

26 June 2028 to 10 June 2036

ChangesThe final date of the exercise period was changed from 25 June 2036 to 10 June 2036.
Reason for correction

Certain matters required correction

What was corrected and how
ItemDetails
Disclosure subject to correctionNotice Concerning the Issuance of Stock Options (Share Acquisition Rights)
Original disclosure date10 June 2026
Location of correction2. Issuance Terms for the Stock Acquisition Rights (4) Period during Which the Stock Acquisition Rights May Be Exercised
Details of correction26 June 2028 to 25 June 2036 → 26 June 2028 to 10 June 2036
Reason for correctionCertain matters required correction
Items this document does not state (1)
Impact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company stated that there was an item requiring partial correction, but did not explain the specific cause.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
(Correction) Partial Correction to the "Notice Concerning the Issuance of Stock Options (Share Acquisition Rights)" | Kringle Pharma,Inc. (4884) timely disclosure | Komori